| __timestamp | Bio-Techne Corporation | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 54823000000 |
| Thursday, January 1, 2015 | 144969000 | 76691000000 |
| Friday, January 1, 2016 | 162364000 | 87477000000 |
| Sunday, January 1, 2017 | 188462000 | 89052000000 |
| Monday, January 1, 2018 | 210850000 | 100745000000 |
| Tuesday, January 1, 2019 | 240515000 | 91915000000 |
| Wednesday, January 1, 2020 | 255497000 | 95905000000 |
| Friday, January 1, 2021 | 298182000 | 104442000000 |
| Saturday, January 1, 2022 | 349103000 | 104437000000 |
| Sunday, January 1, 2023 | 366887000 | 112009000000 |
| Monday, January 1, 2024 | 389335000 | 121134000000 |
In pursuit of knowledge
In the ever-evolving landscape of the biotech and pharmaceutical industries, understanding cost dynamics is crucial. Bio-Techne Corporation and Walgreens Boots Alliance, Inc. offer a fascinating study in contrasts. From 2014 to 2024, Bio-Techne's cost of revenue has surged by approximately 266%, reflecting its aggressive growth strategy and expanding market footprint. In contrast, Walgreens Boots Alliance, a stalwart in the retail pharmacy sector, has seen a more modest increase of around 121% over the same period.
Bio-Techne's cost of revenue, starting at $106 million in 2014, has steadily climbed, reaching nearly $389 million by 2024. Meanwhile, Walgreens Boots Alliance began with a staggering $54.8 billion in 2014, growing to an impressive $121 billion by 2024. This data underscores the differing scales and growth trajectories of these industry leaders, offering valuable insights for investors and analysts alike.
Pfizer Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Neurocrine Biosciences, Inc. vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Viatris Inc. vs Bio-Techne Corporation
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Cost of Revenue Trends: Bio-Techne Corporation vs Corcept Therapeutics Incorporated
Cost of Revenue Trends: Bio-Techne Corporation vs MorphoSys AG
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Lantheus Holdings, Inc.
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Telix Pharmaceuticals Limited
Walgreens Boots Alliance, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored